130 related articles for article (PubMed ID: 23890289)
1. Establishment of erythroleukemic GAK14 cells and characterization of GATA1 N-terminal domain.
Mukai HY; Suzuki M; Nagano M; Ohmori S; Otsuki A; Tsuchida K; Moriguchi T; Ohneda K; Shimizu R; Ohneda O; Yamamoto M
Genes Cells; 2013 Oct; 18(10):886-98. PubMed ID: 23890289
[TBL] [Abstract][Full Text] [Related]
2. Contribution of GATA1 dysfunction to multi-step leukemogenesis.
Shimizu R; Yamamoto M
Cancer Sci; 2012 Dec; 103(12):2039-44. PubMed ID: 22937757
[TBL] [Abstract][Full Text] [Related]
3. Loss of the Gata1 gene IE exon leads to variant transcript expression and the production of a GATA1 protein lacking the N-terminal domain.
Kobayashi E; Shimizu R; Kikuchi Y; Takahashi S; Yamamoto M
J Biol Chem; 2010 Jan; 285(1):773-83. PubMed ID: 19854837
[TBL] [Abstract][Full Text] [Related]
4. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
[TBL] [Abstract][Full Text] [Related]
5. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
Shimizu R; Kobayashi E; Engel JD; Yamamoto M
Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus.
Byrska-Bishop M; VanDorn D; Campbell AE; Betensky M; Arca PR; Yao Y; Gadue P; Costa FF; Nemiroff RL; Blobel GA; French DL; Hardison RC; Weiss MJ; Chou ST
J Clin Invest; 2015 Mar; 125(3):993-1005. PubMed ID: 25621499
[TBL] [Abstract][Full Text] [Related]
7. Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment.
Abe K; Shimizu R; Pan X; Hamada H; Yoshikawa H; Yamamoto M
Exp Hematol; 2009 Apr; 37(4):435-445.e1. PubMed ID: 19302918
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.
Wierenga AT; Vellenga E; Schuringa JJ
Blood; 2010 Jun; 115(22):4367-76. PubMed ID: 20339093
[TBL] [Abstract][Full Text] [Related]
9. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
10. Homotypic signalling regulates Gata1 activity in the erythroblastic island.
Gutiérrez L; Lindeboom F; Langeveld A; Grosveld F; Philipsen S; Whyatt D
Development; 2004 Jul; 131(13):3183-93. PubMed ID: 15175249
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
12. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
13. Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress.
Sanchez M; Weissman IL; Pallavicini M; Valeri M; Guglielmelli P; Vannucchi AM; Migliaccio G; Migliaccio AR
Stem Cells; 2006 Feb; 24(2):337-48. PubMed ID: 16144876
[TBL] [Abstract][Full Text] [Related]
14. Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity.
Sadvakassova G; Dobocan MC; Difalco MR; Congote LF
J Cell Physiol; 2009 Sep; 220(3):672-9. PubMed ID: 19441079
[TBL] [Abstract][Full Text] [Related]
15. Regulation of GATA1 levels in erythropoiesis.
Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
[TBL] [Abstract][Full Text] [Related]
16. Loss of gata1 but not gata2 converts erythropoiesis to myelopoiesis in zebrafish embryos.
Galloway JL; Wingert RA; Thisse C; Thisse B; Zon LI
Dev Cell; 2005 Jan; 8(1):109-16. PubMed ID: 15621534
[TBL] [Abstract][Full Text] [Related]
17. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
18. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
Liu B; Ohishi K; Yamamura K; Suzuki K; Monma F; Ino K; Nishii K; Masuya M; Sekine T; Heike Y; Takaue Y; Katayama N
Exp Hematol; 2010 Aug; 38(8):685-95. PubMed ID: 20381581
[TBL] [Abstract][Full Text] [Related]
19. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
[TBL] [Abstract][Full Text] [Related]
20. Abnormal differentiation of erythroid precursors in p45 NF-E2(-/-) mice.
Gasiorek JJ; Nouhi Z; Blank V
Exp Hematol; 2012 May; 40(5):393-400. PubMed ID: 22265708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
